Main article

Agendia remains focused on becoming a competitive force in the breast cancer prognostic market long dominated by Genomic Health’s Oncotype DX and now has additional financial resources to pursue this goal.

Subscribers: click here for the full story

Non-Subscribers: click here to subscribe

November 2009 - Table of Contents

LIR November 2009 (Full PDF Issue)

Industry Buzz : Agendia Raises $23 Million in Series E Financing

Industry Concern Intensifies Over Health Care Reform Cuts; Over 40% of Lab Institute Attendees Say Greater Government Involvement Bad for Business

Quest’s Q3 Revenue Grows 3.9% to $1.9 Billion; Revenue-Per-Requisition Grows 3.4%

Obama Administration Cites Need for Data on Role of Diagnostic Testing in Prevention

CAP Proposes Three-Tiered Oversight Approach of Lab-Developed Tests

Inside the Lab Industry: Lab Execs Sound Off on Reform’s Impact on Shrinking Margins, Increasing Volumes at 27th Annual Lab Institute

Geisinger’s Proven Diagnostics Collaborates With ViraCor-IBT Labs

Lab Index Dips in Fall; Down 5% Over Five Weeks, but Up 40% for Full Year 2009

San Diego-Based AlliedPath’s New CLIA Lab to Focus on Solid Tumor Testing Services